Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AQA-0325 by Aquavit Pharmaceuticals for Unspecified Neurologic Disorders: Likelihood of Approval
AQA-0325 is under clinical development by Aquavit Pharmaceuticals and currently in Phase I for Unspecified Neurologic Disorders. According to GlobalData,...